Vertebroplasty And Kyphoplasty Devices Market Overview (2022-2032)

[250 Pages Report] The vertebroplasty and kyphoplasty devices market is expected to record a CAGR of 4.4% during the forecast period.

Attributes Details
Vertebroplasty and Kyphoplasty Devices Market CAGR 4.4%
Vertebroplasty and Kyphoplasty Devices Market (2018) US$ 1 Billion

Sales of vertebroplasty and kyphoplasty devices are expected to rise as they are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF).

Back pain, depression, loss of independence, decreased lung capacity, and difficulty sleeping can all result from VCFs. Hence, treating the same carries importance which surges the demand for vertebroplasty and kyphoplasty devices.

In addition, the higher sales of vertebroplasty and kyphoplasty devices can be attributed to the help that it provides to the patient to regain functional abilities and avoid further vertebral collapse.

Demand for vertebroplasty and kyphoplasty devices spikes as kyphoplasty is an advanced version of vertebroplasty that can stabilize the fracture, restore heights and reduce deformities.

The syringe can be used to inject cement as well as inflate and deflate interventional devices. As a result, these factors are expected to increase the demand for vertebroplasty and kyphoplasty devices.

Due to people's changing lifestyles, the sales of vertebroplasty and kyphoplasty devices are expected to grow significantly.

Furthermore, an increase in demand for minimally invasive spine surgery procedures propels the demand for vertebroplasty and kyphoplasty devices and in turn, the sales of vertebroplasty and kyphoplasty devices.

The demand for vertebroplasty and kyphoplasty devices is being driven by an ageing population, which has resulted in an increase in the number of vertebral compression fractures and an increase in health-care expenditure.

Although specialty antibody applications are specifically used in research and diagnostic procedures, hospitals are a major end-user and the same facilitates the high demand for vertebroplasty and kyphoplasty devices.

The rising sales of vertebroplasty and kyphoplasty devices is also due to the improved hospital infrastructure in the United States, Europe, and other developed countries is strong.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Who are Some of the Major Players in the Vertebroplasty and Kyphoplasty Devices Market?

Demand for vertebroplasty and kyphoplasty devices is growing due to limitations in the traditional techniques for the treatment of vertebral compression fractures.

Vertebroplasty and kyphoplasty are advanced procedure which result in pain relief, stabilization of the fracture and avoid “Downward spiral” of untreated osteoporosis thereby spikes the sales of vertebroplasty and kyphoplasty devices.

Due to increase in ageing population, patients suffering from osteoporosis are also increasing the sales of vertebroplasty and kyphoplasty devices.

The rising demand for vertebroplasty and kyphoplasty devices can be contributed to benefit of the surgery such as short surgical time where patient gets discharged in less than one day.

Sales of vertebroplasty and kyphoplasty devices grow as surgery involves requirement of general anaesthesia and non-requirement of bracing.

Complications like bleeding, infection post-surgery and chances of occurrence of another fracture are few restraints for the demand for vertebroplasty and kyphoplasty devices.

VCF is a major issue in the western countries driving the demand for vertebroplasty and kyphoplasty devices and in turn, sales of vertebroplasty and kyphoplasty devices.

Overall sales of vertebroplasty and kyphoplasty devices will grow globally, however the growth rate in Asia Pacific region will be more as compared to European and North American market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Why is North America at the Forefront of the Vertebroplasty and Kyphoplasty Devices Market?

Depending on geographic regions, the global vertebroplasty and kyphoplasty devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America is the holding a major porting of the vertebroplasty and kyphoplasty devices market share due to the high volumes of surgical procedures being performed.

Also, the availability of established healthcare infrastructure, high contribution of healthcare to economy, patient compliance are the reasons for the high vertebroplasty and kyphoplasty devices market share of North America.

North America’s vertebroplasty and kyphoplasty devices market share can also be credited to the high prices of the kyphoplasty procedure in the United States, as well as the country's high incidence rate of vertebral compression fractures.

Europe has the second largest vertebroplasty and kyphoplasty devices market share due to vast technological advancement in terms of healthcare sector.

Asia Pacific market is expected to witness a good vertebroplasty and kyphoplasty devices market growth rate as compared to North America and Europe as there is ample market opportunity in countries like India and China.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Who are the Key Players in the Vertebroplasty and Kyphoplasty Devices Market?

Some of the key market players in global vertebroplasty and kyphoplasty devices market are Depuy Synthes, Stryker Corporation, CareFusion Corporation, Osseon LLC., Alphatec Spine, Inc., TAEYEON MEDICAL Co., Ltd.

In terms of vertebroplasty and kyphoplasty devices market share, a few major players currently dominate the market.

Companies have been launching strategic initiatives to expand their presence in the market under consideration.

  • Medtronic acquired Titan Spine to expand its spinal surgery product portfolio.
  • Stryker's AVAflex balloon system for treating vertebral compression fractures has been approved by the FDA. This technology was purchased by the company from BD.
Report Attributes Details
Growth rate CAGR of 4.4% from 2022 to 2032
Base year for estimation 2021
Historical data 2015 to 2020
Forecast period 2022 to 2032
Quantitative units Revenue in US$ million, volume in kilotons, and CAGR from 2022 to 2032
Report coverage Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments covered Product, Region
Regional scope North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled Depuy Synthes, Stryker Corporation, CareFusion Corporation, Osseon LLC., Alphatec Spine, Inc., TAEYEON MEDICAL Co., Ltd., G-21 s.r.l., BMK Global Medical Company, Medtronic, Inc., Globus Medical, Inc. and SOMATEX.
Customization scope Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail customized purchase options to meet your exact research needs.?

Key Segments

By Product:

  • Vertebroplasty Devices
  • Kyphoplasty Devices

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

What is the Growth Outlook of the Vertebroplasty and Kyphoplasty Devices Market?

The vertebroplasty and kyphoplasty devices market likely registers a CAGR of 4.4% during the forecast period.

Which Region has the Highest Growth Rate in the Vertebroplasty and Kyphoplasty Devices Market?

Asia Pacific is expanding at the fastest rate owing to broad vertebroplasty and kyphoplasty devices market opportunities.

Who are the Key Players in the Vertebroplasty and Kyphoplasty Devices Market?

Depuy Synthes, Stryker Corporation, CareFusion Corporation, Osseon LLC., Alphatec Spine, Inc., TAEYEON MEDICAL Co., Ltd. are some of the key players in the vertebroplasty and kyphoplasty devices market.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
    4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
    4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product, 2017-2021
    5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product, 2022-2032
        5.3.1. Vertebroplasty Devices
        5.3.2. Kyphoplasty Devices
    5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021
    5.5. Absolute $ Opportunity Analysis By Product, 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Surgery
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Surgery, 2017-2021
    6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Surgery, 2022-2032
        6.3.1. Vertebroplasty
        6.3.2. Kyphoplasty
    6.4. Y-o-Y Growth Trend Analysis By Surgery, 2017-2021
    6.5. Absolute $ Opportunity Analysis By Surgery, 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021
    7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032
        7.3.1. Hospitals
        7.3.2. Ambulatory Surgical Centers
        7.3.3. Speciality Clinics
    7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
Deep-dive segmentation will be available in the sample on request
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
    8.1. Introduction
    8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
    8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
        8.3.1. North America
        8.3.2. Latin America
        8.3.3. Europe
        8.3.4. East Asia
        8.3.5. South Asia & Pacific
        8.3.6. MEA
    8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
    9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
        9.2.1. By Country
            9.2.1.1. U.S.
            9.2.1.2. Canada
        9.2.2. By Product
        9.2.3. By Surgery
        9.2.4. By End User
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Product
        9.3.3. By Surgery
        9.3.4. By End User
    9.4. Key Takeaways
10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
    10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
        10.2.1. By Country
            10.2.1.1. Brazil
            10.2.1.2. Mexico
            10.2.1.3. Rest of Latin America
        10.2.2. By Product
        10.2.3. By Surgery
        10.2.4. By End User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product
        10.3.3. By Surgery
        10.3.4. By End User
    10.4. Key Takeaways
11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
    11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
        11.2.1. By Country
            11.2.1.1. Germany
            11.2.1.2. U.K.
            11.2.1.3. France
            11.2.1.4. Spain
            11.2.1.5. Italy
            11.2.1.6. Rest of Europe
        11.2.2. By Product
        11.2.3. By Surgery
        11.2.4. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product
        11.3.3. By Surgery
        11.3.4. By End User
    11.4. Key Takeaways
12. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
    12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
        12.2.1. By Country
            12.2.1.1. China
            12.2.1.2. Japan
            12.2.1.3. South Korea
        12.2.2. By Product
        12.2.3. By Surgery
        12.2.4. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By Surgery
        12.3.4. By End User
    12.4. Key Takeaways
13. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
    13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
        13.2.1. By Country
            13.2.1.1. India
            13.2.1.2. Thailand
            13.2.1.3. Indonesia
            13.2.1.4. Malaysia
            13.2.1.5. Singapore
            13.2.1.6. Australia
            13.2.1.7. New Zealand
            13.2.1.8. Rest of South Asia & Pacific
        13.2.2. By Product
        13.2.3. By Surgery
        13.2.4. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By Surgery
        13.3.4. By End User
    13.4. Key Takeaways
14. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
    14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
        14.2.1. By Country
            14.2.1.1. GCC Countries
            14.2.1.2. South Africa
            14.2.1.3. Israel
            14.2.1.4. Rest of MEA
        14.2.2. By Product
        14.2.3. By Surgery
        14.2.4. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product
        14.3.3. By Surgery
        14.3.4. By End User
    14.4. Key Takeaways
15. Key Countries Market Analysis
    15.1. U.S.
        15.1.1. Pricing Analysis
        15.1.2. Market Share Analysis, 2021
            15.1.2.1. By Product
            15.1.2.2. By Surgery
            15.1.2.3. By End User
    15.2. Canada
        15.2.1. Pricing Analysis
        15.2.2. Market Share Analysis, 2021
            15.2.2.1. By Product
            15.2.2.2. By Surgery
            15.2.2.3. By End User
    15.3. Brazil
        15.3.1. Pricing Analysis
        15.3.2. Market Share Analysis, 2021
            15.3.2.1. By Product
            15.3.2.2. By Surgery
            15.3.2.3. By End User
    15.4. Mexico
        15.4.1. Pricing Analysis
        15.4.2. Market Share Analysis, 2021
            15.4.2.1. By Product
            15.4.2.2. By Surgery
            15.4.2.3. By End User
    15.5. Germany
        15.5.1. Pricing Analysis
        15.5.2. Market Share Analysis, 2021
            15.5.2.1. By Product
            15.5.2.2. By Surgery
            15.5.2.3. By End User
    15.6. U.K.
        15.6.1. Pricing Analysis
        15.6.2. Market Share Analysis, 2021
            15.6.2.1. By Product
            15.6.2.2. By Surgery
            15.6.2.3. By End User
    15.7. France
        15.7.1. Pricing Analysis
        15.7.2. Market Share Analysis, 2021
            15.7.2.1. By Product
            15.7.2.2. By Surgery
            15.7.2.3. By End User
    15.8. Spain
        15.8.1. Pricing Analysis
        15.8.2. Market Share Analysis, 2021
            15.8.2.1. By Product
            15.8.2.2. By Surgery
            15.8.2.3. By End User
    15.9. Italy
        15.9.1. Pricing Analysis
        15.9.2. Market Share Analysis, 2021
            15.9.2.1. By Product
            15.9.2.2. By Surgery
            15.9.2.3. By End User
    15.10. China
        15.10.1. Pricing Analysis
        15.10.2. Market Share Analysis, 2021
            15.10.2.1. By Product
            15.10.2.2. By Surgery
            15.10.2.3. By End User
    15.11. Japan
        15.11.1. Pricing Analysis
        15.11.2. Market Share Analysis, 2021
            15.11.2.1. By Product
            15.11.2.2. By Surgery
            15.11.2.3. By End User
    15.12. South Korea
        15.12.1. Pricing Analysis
        15.12.2. Market Share Analysis, 2021
            15.12.2.1. By Product
            15.12.2.2. By Surgery
            15.12.2.3. By End User
    15.13. India
        15.13.1. Pricing Analysis
        15.13.2. Market Share Analysis, 2021
            15.13.2.1. By Product
            15.13.2.2. By Surgery
            15.13.2.3. By End User
    15.14. Thailand
        15.14.1. Pricing Analysis
        15.14.2. Market Share Analysis, 2021
            15.14.2.1. By Product
            15.14.2.2. By Surgery
            15.14.2.3. By End User
    15.15. Indonesia
        15.15.1. Pricing Analysis
        15.15.2. Market Share Analysis, 2021
            15.15.2.1. By Product
            15.15.2.2. By Surgery
            15.15.2.3. By End User
    15.16. Malaysia
        15.16.1. Pricing Analysis
        15.16.2. Market Share Analysis, 2021
            15.16.2.1. By Product
            15.16.2.2. By Surgery
            15.16.2.3. By End User
    15.17. Singapore
        15.17.1. Pricing Analysis
        15.17.2. Market Share Analysis, 2021
            15.17.2.1. By Product
            15.17.2.2. By Surgery
            15.17.2.3. By End User
    15.18. Australia
        15.18.1. Pricing Analysis
        15.18.2. Market Share Analysis, 2021
            15.18.2.1. By Product
            15.18.2.2. By Surgery
            15.18.2.3. By End User
    15.19. New Zealand
        15.19.1. Pricing Analysis
        15.19.2. Market Share Analysis, 2021
            15.19.2.1. By Product
            15.19.2.2. By Surgery
            15.19.2.3. By End User
    15.20. GCC Countries
        15.20.1. Pricing Analysis
        15.20.2. Market Share Analysis, 2021
            15.20.2.1. By Product
            15.20.2.2. By Surgery
            15.20.2.3. By End User
    15.21. South Africa
        15.21.1. Pricing Analysis
        15.21.2. Market Share Analysis, 2021
            15.21.2.1. By Product
            15.21.2.2. By Surgery
            15.21.2.3. By End User
    15.22. Israel
        15.22.1. Pricing Analysis
        15.22.2. Market Share Analysis, 2021
            15.22.2.1. By Product
            15.22.2.2. By Surgery
            15.22.2.3. By End User
16. Market Structure Analysis
    16.1. Competition Dashboard
    16.2. Competition Benchmarking
    16.3. Market Share Analysis of Top Players
        16.3.1. By Regional
        16.3.2. By Product
        16.3.3. By Surgery
        16.3.4. By End User
17. Competition Analysis
    17.1. Competition Deep Dive
        17.1.1. Depuy Synthes
            17.1.1.1. Overview
            17.1.1.2. Product Portfolio
            17.1.1.3. Profitability by Market Segments
            17.1.1.4. Sales Footprint
            17.1.1.5. Strategy Overview
                17.1.1.5.1. Marketing Strategy
                17.1.1.5.2. Product Strategy
                17.1.1.5.3. Channel Strategy
        17.1.2. Stryker Corporation
            17.1.2.1. Overview
            17.1.2.2. Product Portfolio
            17.1.2.3. Profitability by Market Segments
            17.1.2.4. Sales Footprint
            17.1.2.5. Strategy Overview
                17.1.2.5.1. Marketing Strategy
                17.1.2.5.2. Product Strategy
                17.1.2.5.3. Channel Strategy
        17.1.3. Becton, Dickinson and Company
            17.1.3.1. Overview
            17.1.3.2. Product Portfolio
            17.1.3.3. Profitability by Market Segments
            17.1.3.4. Sales Footprint
            17.1.3.5. Strategy Overview
                17.1.3.5.1. Marketing Strategy
                17.1.3.5.2. Product Strategy
                17.1.3.5.3. Channel Strategy
        17.1.4. Osteon Medical
            17.1.4.1. Overview
            17.1.4.2. Product Portfolio
            17.1.4.3. Profitability by Market Segments
            17.1.4.4. Sales Footprint
            17.1.4.5. Strategy Overview
                17.1.4.5.1. Marketing Strategy
                17.1.4.5.2. Product Strategy
                17.1.4.5.3. Channel Strategy
        17.1.5. Alphatec Spine, Inc.
            17.1.5.1. Overview
            17.1.5.2. Product Portfolio
            17.1.5.3. Profitability by Market Segments
            17.1.5.4. Sales Footprint
            17.1.5.5. Strategy Overview
                17.1.5.5.1. Marketing Strategy
                17.1.5.5.2. Product Strategy
                17.1.5.5.3. Channel Strategy
        17.1.6. G-21 s.r.l.
            17.1.6.1. Overview
            17.1.6.2. Product Portfolio
            17.1.6.3. Profitability by Market Segments
            17.1.6.4. Sales Footprint
            17.1.6.5. Strategy Overview
                17.1.6.5.1. Marketing Strategy
                17.1.6.5.2. Product Strategy
                17.1.6.5.3. Channel Strategy
        17.1.7. BMK Global Medical Company
            17.1.7.1. Overview
            17.1.7.2. Product Portfolio
            17.1.7.3. Profitability by Market Segments
            17.1.7.4. Sales Footprint
            17.1.7.5. Strategy Overview
                17.1.7.5.1. Marketing Strategy
                17.1.7.5.2. Product Strategy
                17.1.7.5.3. Channel Strategy
        17.1.8. Medtronic, Inc.
            17.1.8.1. Overview
            17.1.8.2. Product Portfolio
            17.1.8.3. Profitability by Market Segments
            17.1.8.4. Sales Footprint
            17.1.8.5. Strategy Overview
                17.1.8.5.1. Marketing Strategy
                17.1.8.5.2. Product Strategy
                17.1.8.5.3. Channel Strategy
        17.1.9. Globus Medical, Inc.
            17.1.9.1. Overview
            17.1.9.2. Product Portfolio
            17.1.9.3. Profitability by Market Segments
            17.1.9.4. Sales Footprint
            17.1.9.5. Strategy Overview
                17.1.9.5.1. Marketing Strategy
                17.1.9.5.2. Product Strategy
                17.1.9.5.3. Channel Strategy
        17.1.10. SOMATEX Medical Technologies GmbH
            17.1.10.1. Overview
            17.1.10.2. Product Portfolio
            17.1.10.3. Profitability by Market Segments
            17.1.10.4. Sales Footprint
            17.1.10.5. Strategy Overview
                17.1.10.5.1. Marketing Strategy
                17.1.10.5.2. Product Strategy
                17.1.10.5.3. Channel Strategy
        17.1.11. TAEYEON MEDICAL Co. Ltd.
            17.1.11.1. Overview
            17.1.11.2. Product Portfolio
            17.1.11.3. Profitability by Market Segments
            17.1.11.4. Sales Footprint
            17.1.11.5. Strategy Overview
                17.1.11.5.1. Marketing Strategy
                17.1.11.5.2. Product Strategy
                17.1.11.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Recommendations

Healthcare

Vertebroplasty Needles Market

December 2022

REP-GB-2235

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Vertebroplasty And Kyphoplasty Devices Market

Schedule a Call